The mouse brain adenosine A1 receptor: Functional expression and pharmacology

European Journal of Pharmacology

Volumn 487, Issue 1-3, 2004, Pages 73-79

  Wittendorp, Maria C ^a   Von Frijtag Drabbe Künzel, Jacobien ^b   Ijzerman, Adriaan P ^b   Boddeke, Hendrikus W G M ^a   Biber, Knut ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b LEIDEN UNIVERSITY   (Netherlands)

Author keywords

Adenosine receptor; Brain; cAMP assay; Mouse; Pharmacology

Indexed keywords

ADENOSINE A1 RECEPTOR; BRAIN RECEPTOR; RADIOLIGAND;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BRAIN; CONTROLLED STUDY; LIGAND BINDING; MOLECULAR CLONING; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION;

AMINO ACID SEQUENCE; ANIMALS; BRAIN CHEMISTRY; CHO CELLS; CLONING, MOLECULAR; CRICETINAE; CYCLIC AMP; FORSKOLIN; HUMANS; INDICATORS AND REAGENTS; MICE; MOLECULAR SEQUENCE DATA; NEUROGLIA; RADIOLIGAND ASSAY; RECEPTOR, ADENOSINE A1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECIES SPECIFICITY;

EID: 1642342103     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2004.01.034     Document Type: Article

References (45)

1. 1 adenosine receptor gene and a related cDNA clone. Biochem. J. 307(Pt. 3):1995;729-734.
2. 1 receptor. J. Med. Chem. 46:2003;1492-1503.
3. 1 receptor-mediated activation of phospholipase C in cultured astrocytes depends on the level of receptor expression. J. Neurosci. 17:1997;4956-4964.
4. Biber K., Sauter A., Brouwer N., Copray S.C., Boddeke H.W. Ischemia-induced neuronal expression of the microglia attracting chemokine Secondary Lymphoid-tissue Chemokine (SLC). Glia. 34:2001;121-133.
5. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
6. Cunha R.A. Adenosine as a neuromodulator and as a homeostatic regulator in the nervous system: different roles, different sources and different receptors. Neurochem. Int. 38:2001;107-125.
7. 1 receptors. Biochem. Pharmacol. 56:1998;1437-1445.
8. Dirnagl U., Niwa K., Lindauer U., Villringer A. Coupling of cerebral blood flow to neuronal activation: role of adenosine and nitric oxide. Am. J. Physiol. 267:1994;296-301.
9. Drury A.N., Szent-Gyorgyi A. The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart. J. Physiol. (Lond.). 68:1929;213-237.
10. Dunwiddie T.V. The physiological role of adenosine in the central nervous system. Int. Rev. Neurobiol. 27:1985;63-139.
11. Fredholm B.B., Abbracchio M.P., Burnstock G., Daly J.W., Harden T.K., Jacobson K.A., Leff P., Williams M. Nomenclature and classification of purinoceptors. Pharmacol. Rev. 46:1994;143-156.
12. Fredholm B.B., Battig K., Holmen J., Nehlig A., Zvartau E.E. Actions of caffeine in the brain with special reference to factors that contribute to its widespread use. Pharmacol. Rev. 51:1999;83-133.
13. Fredholm B.B., AP I.J., Jacobson K.A., Klotz K.N., Linden J. International Union of Pharmacology: XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev. 53:2001;527-552.
14. 1 receptor are anxious and aggressive, but are normal learners with reduced muscle strength and survival rate. Eur. J. Neurosci. 16:2002;547-550.
15. Haas H.L., Selbach O. Functions of neuronal adenosine receptors. Naunyn-Schmiedeberg's Arch. Pharmacol. 362:2000;375-381.
16. 1 receptor. Proc. Natl. Acad. Sci. U. S. A. 98:2001;9407-9412.
17. Kaiser S.M., Quinn R.J. Adenosine receptors as potential therapeutic targets. Drug Discov. Today. 4:1999;542-551.
18. Klotz K.N., Hessling J., Hegler J., Owman C., Kull B., Fredholm B.B., Lohse M.J. Comparative pharmacology of human adenosine receptor subtypes - characterization of stably transfected receptors in CHO cells. Naunyn-Schmiedeberg's Arch. Pharmacol. 357:1998;1-9.
19. 2a receptor. Nature. 388:1997;674-678.
20. Libert F., Parmentier M., Lefort A., Dinsart C., Van Sande J., Maenhaut C., Simons M.J., Dumont J.E., Vassart G. Selective amplification and cloning of four new members of the G protein-coupled receptor family. Science. 244:1989;569-572.
21. 1 adenosine receptor. Biochem. Biophys. Res. Commun. 187:1992;919-926.
22. Linden J. Molecular approach to adenosine receptors: receptor-mediated mechanisms of tissue protection. Annu. Rev. Pharmacol. Toxicol. 41:2001;775-787.
23. Lohse M.J., Lenschow V., Schwabe U. Interaction of barbiturates with adenosine receptors in rat brain. Naunyn-Schmiedeberg's Arch. Pharmacol. 326:1984;69-74.
24. 1 receptor pharmacology revealed by use of xanthine and pyrazolopyridine based antagonists. Br. J. Pharmacol. 122:1997;1202-1208.
25. Mahan L.C., McVittie L.D., Smyk-Randall E.M., Nakata H., Monsma F.J. Jr., Gerfen C.R., Sibley D.R. Cloning and expression of an A1 adenosine receptor from rat brain. Mol. Pharmacol. 40:1991;1-7.
26. Marquardt D.L., Walker L.L., Heinemann S. Cloning of two adenosine receptor subtypes from mouse bone marrow-derived mast cells. J. Immunol. 152:1994;4508-4515.
27. 1 adenosine receptor from guinea pig brain. Brain Res. Mol. Brain Res. 26:1994;143-155.
28. Mubagwa K., Flameng W. Adenosine, adenosine receptors and myocardial protection: an updated overview. Cardiovasc. Res. 52:2001;25-39.
29. 3 receptor gene. FEBS Lett. 384:1996;243-246.
30. Nyce J.W. Insight into adenosine receptor function using antisense and gene-knockout approaches. Trends Pharmacol. Sci. 20:1999;79-83.
31. Olah M.E., Stiles G.L. Adenosine receptor subtypes: characterization and therapeutic regulation. Annu. Rev. Pharmacol. Toxicol. 35:1995;581-606.
32. Olah M.E., Ren H., Ostrowski J., Jacobson K.A., Stiles G.L. Cloning, expression, and characterization of the unique bovine A1 adenosine receptor. Studies on the ligand binding site by site-directed mutagenesis. J. Biol. Chem. 267:1992;10764-10770.
33. 2b receptor from human brain. Biochem. Biophys. Res. Commun. 187:1992;86-93.
34. 6-(omega-aminoalkyl)adenosines on adenosine receptor affinity and intrinsic activity. Eur. J. Pharmacol. 172:1989;185-193.
35. Ribeiro J.A., Sebastiao A.M., de Mendonca A. Adenosine receptors in the nervous system: pathophysiological implications. Prog. Neurobiol. 68:2002;377-392.
36. Rudolphi K.A., Schubert P. Purinergic interventions in traumatic and ischemic injury. Peterson P.L., Willis P.J. Novel Thearapies for CNS Injuries. 1996;327-342 CRC Press, Boca Raton.
37. Schulte G., Fredholm B.B. Signalling from adenosine receptors to mitogen-activated protein kinases. Cell. Signal. 15:2003;813-827.
38. Stone T.W. Purines and neuroprotection. Adv. Exp. Med. Biol. 513:2002;249-280.
39. Tabrizchi R., Bedi S. Pharmacology of adenosine receptors in the vasculature. Pharmacol. Ther. 91:2001;133-147.
40. Tatsis-Kotsidis I., Erlanger B.F. A1 adenosine receptor of human and mouse adipose tissues: cloning, expression, and characterization. Biochem. Pharmacol. 58:1999;1269-1277.
41. 1 receptor. Eur. J. Pharmacol. 290:1995;189-199.
42. Williams M., Jarvis M.F. Purinergic and pyrimidinergic receptors as potential drug targets. Biochem. Pharmacol. 59:2000;1173-1185.
43. 3 adenosine receptor gene: exon/intron organization and promoter activity. Genomics. 57:1999;152-155.
44. 3 adenosine receptor in determining tissue levels of cAMP and blood pressure: studies in knock-out mice. Biochim. Biophys. Acta. 1500:2000;280-290.
45. 3 adenosine receptor. Proc. Natl. Acad. Sci. U. S. A. 89:1992;7432-7436.